(Q45049144)

8 December 2017

title

Effects of serotonin transporter promoter polymorphisms on serotonin function (English)

1 reference

8 December 2017

0 references

8

David Eidelberg

1 reference

8 December 2017

7

Peter K Gregersen

1 reference

8 December 2017

6

Elisse Kramer

1 reference

8 December 2017

Gwenn S Smith

1

1 reference

8 December 2017

Francis E Lotrich

2

1 reference

8 December 2017

Anil K Malhotra

3

1 reference

8 December 2017

Annette T Lee

4

1 reference

8 December 2017

Yilong Ma

5

1 reference

8 December 2017

Bruce G Pollock

9

1 reference

8 December 2017

language of work or name

English

0 references

publication date

1 December 2004

1 reference

8 December 2017

published in

Neuropsychopharmacology

1 reference

8 December 2017

volume

29

1 reference

8 December 2017

issue

12

1 reference

8 December 2017

page(s)

2226-2234

1 reference

Reproducibility of cerebral glucose metabolic measurements in resting human subjects.

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

Cerebral glucose metabolism in women with panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

Does stress damage the brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

Frontal EEG asymmetry and the behavioral activation and inhibition systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

The neural substrates of affective processing in depressed patients treated with venlafaxine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

A novel allelic variant of the human serotonin transporter gene regulatory polymorphism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

Striatal binding of the PET ligand 11C-raclopride is altered by drugs that modify synaptic dopamine levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

Allelic variation in the serotonin transporter promoter affects neuromodulatory effects of a selective serotonin transporter reuptake inhibitor (SSRI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

The mind's eye--precuneus activation in memory-related imagery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

Statistical parametric maps in functional imaging: A general linear approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

Serotonin modulation of cerebral glucose metabolism in normal aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

SM-20220, a potent Na+/H+ exchange inhibitor, improves consciousness recovery and neurological outcome following transient cerebral ischaemia in gerbils

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

Serotonin transporter genetic variation and the response of the human amygdala

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

Allelic Variation of Human Serotonin Transporter Gene Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

Serotonergic modulation of hippocampal acetylcholine release after long-term neuronal grafting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

Effect of 5-HT on binding of [(11)C] WAY 100635 to 5-HT(IA) receptors in rat brain, assessed using in vivo microdialysis nd PET after fenfluramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

Effect of 5-HT1A receptor antagonists on citalopram-induced increase in extracellular serotonin in the frontal cortex, striatum and dorsal hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

Monoamines and their metabolites in somatosensory, visual, and cingulate cortices of adult rat: differences in content and lack of sidedness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

Serotonin transporter polymorphisms: no association with response to antipsychotic treatment, but associations with the schizoparanoid and residual subtypes of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

The presence of a serotonin uptake inhibitor alters pharmacological manipulations of serotonin release

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

Polymorphism of the serotonin transporter: implications for the use of selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

Differential limbic--cortical correlates of sadness and anxiety in healthy subjects: implications for affective disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

The electrophysiology of prefrontal serotonin systems: therapeutic implications for mood and psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

Remote lateralized changes in cortical [3H]spiperone binding following focal frontal cortex lesions in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

Serotonin in aging, late-life depression, and Alzheimer's disease: the emerging role of functional imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

The effects of single dose nefazodone and paroxetine upon 5-HT2A binding potential in humans using [18F]-setoperone PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

Serotonin transporter function is modulated by brain-derived neurotrophic factor (BDNF) but not nerve growth factor (NGF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

Allelic variation of serotonin transporter expression is associated with depression in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

Pharmacogenetics of antidepressant medication intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

Initial conditions of serotonin transporter kinetics and genotype: influence on SSRI treatment trial outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

Serotonin transporter promoter polymorphism is associated with attenuated prolactin response to fenfluramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

Visualisation of loss of 5-HT2A receptors with age in healthy volunteers using [18F]altanserin and positron emission tomographic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

Association of dopaminergic and serotonergic genes with tardive dyskinesia in patients with chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

Neuroendocrine effects of a 20-mg citalopram infusion in healthy males. A placebo-controlled evaluation of citalopram as 5-HT function probe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

No association between genotype of the promoter region of serotonin transporter gene and serotonin transporter binding in human brain measured by PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

Serotonin modulation of cerebral glucose metabolism measured with positron emission tomography (PET) in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

Cerebral glucose utilization is reduced in second test session

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

Allelic variation in serotonin transporter function associated with the intensity dependence of the auditory evoked potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

The 5-HTTPR*S/*L polymorphism and aggressive behavior in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

Noninvasive quantitative fluorodeoxyglucose PET studies with an estimated input function derived from a population-based arterial blood curve

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

Serotonin 5-HT1A receptor binding potential declines with age as measured by [11C]WAY-100635 and PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

Imaging endogenous dopamine competition with [11C]raclopride in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

No evidence for in vivo regulation of midbrain serotonin transporter availability by serotonin transporter promoter gene polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

The citalopram challenge test in patients with major depression and in healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

Positron Emission Tomographic Imaging of Serotonin Activation Effects on Prefrontal Cortex in Healthy Volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

Improved method for detecting the long and short promoter alleles of the serotonin transporter gene HTT (SLC6A4)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

7 January 2021

Population studies of polymorphisms of the serotonin transporter protein gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

7 January 2021

Glucocorticoid-regulated human serotonin transporter (5-HTT) expression is modulated by the 5-HTT gene-promotor-linked polymorphic region

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

7 January 2021

Serotonin transporter gene polymorphism and antidepressant response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

7 January 2021

Endogenous serotonin enhances the release of dopamine in the striatum only when nigro-striatal dopaminergic transmission is activated

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

7 January 2021

Inhibition of 5-hydroxytryptamine reuptake by the antidepressant citalopram in the locus coeruleus modulates the rat brain noradrenergic transmission in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

7 January 2021

Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

7 January 2021

Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

7 January 2021

A fenfluramine-activated FDG-PET study of borderline personality disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

7 January 2021

Do genetic polymorphisms of serotonin (5-HT) neurotransmission influence function in humans?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

7 January 2021

The 5-HTTPR polymorphism confers liability to a combined phenotype of psychotic and aggressive behavior in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

7 January 2021

Serotonin transporter (5-HTT) promoter genotype may influence the prolactin response to clomipramine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300552

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300552

1 reference

Dimensions Publication ID

8 December 2017

1022894215

0 references

1 reference